Capstone Investment Advisors, LLC Edwards Lifesciences Corp Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 24,789 shares of EW stock, worth $1.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,789

Previous 37,300 33.54%

Holding current value

$1.87 Million

Previous $3.45 Million 52.54%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $1.3 Million - $2.05 Million	21,818 Added 734.37%	24,789 $1.64 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $142,972 - $159,949	-1,696 Reduced 36.34%	2,971 $274,000
Q1 2024 May 01, 2024	BUY	$72.54 - $95.56 $338,544 - $445,978	4,667 New	4,667 $445,000
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $1.08 Million - $1.46 Million	15,593 Added 10395.33%	15,743 $1.09 Million
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $11,478 - $13,300	141 Added 1566.67%	150 $14,000
Q1 2023 May 09, 2023	SELL	$74.26 - $84.51 $681,632 - $775,717	-9,179 Reduced 99.9%	9 $0
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $2.84 Million - $3.63 Million	-41,513 Reduced 81.88%	9,188 $685,000
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $2.6 Million - $3.39 Million	31,568 Added 164.99%	50,701 $4.19 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $1.53 Million - $2.27 Million	17,717 Added 1251.2%	19,133 $1.82 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $903,711 - $1.13 Million	-10,779 Reduced 88.39%	1,416 $146,000
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $1.82 Million - $2.09 Million	-23,092 Reduced 65.44%	12,195 $1.02 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.42 Million - $1.89 Million	24,622 Added 230.87%	35,287 $2.44 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $17,400 - $26,892	-332 Reduced 3.02%	10,665 $2.01 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $787,839 - $902,004	10,988 Added 122088.89%	10,997 $2.57 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $2,585 - $3,168	-42 Reduced 82.35%	9 $2,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $111 - $128	2 Added 4.08%	51 $9,000
Q1 2019 Aug 15, 2019	SELL	$47.89 - $64.05 $4,262 - $5,700	-89 Reduced 64.49%	49 $9,000
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $2,413 - $2,960	52 Added 60.47%	138 $21,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $3,930 - $4,990	86 New	86 $15,000
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $513,506 - $598,609	-15,197 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $551,499 - $590,099	15,197	15,197 $1.66 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Edwards Lifesciences Corp Transaction History